A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.
Ann Oncol
; 25(7): 1328-1333, 2014 Jul.
Article
en En
| MEDLINE
| ID: mdl-24603643
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Piridinas
/
Quinuclidinas
/
Vómitos
/
Isoquinolinas
/
Antieméticos
/
Náusea
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Guideline
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2014
Tipo del documento:
Article